Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best multibagger stocks to invest in right now. The company’s focus lies on its lead asset, Seralutinib, which targets pulmonary arterial hypertension (PAH), a severe condition with limited treatment options. Investor enthusiasm for the stock has grown markedly this year. It was trading around $1 at the start of the year and has since climbed to $2.50, delivering nearly 180% returns year-to-date. Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Goss ...